Designates May 17, 2017, as Diffuse Intrinsic Pontine Glioma (DIPG) Awareness Day.
Impact
The passage of SCR33 is largely symbolic but aims to catalyze discussions around the pressing issue of pediatric brain cancer. While the resolution does not create new laws or regulations, it emphasizes the health crisis facing children diagnosed with DIPG and the overall lack of funding allocated to pediatric cancer research. Currently, only a small fraction of the National Cancer Institute's budget is directed towards research in this area, which underscores the need for increased awareness and advocacy. By designating a special day, the resolution hopes to bring attention to the need for more comprehensive studies and treatment options for this devastating disease.
Summary
Senate Concurrent Resolution 33 (SCR33) is a resolution that aims to designate May 17, 2017, as Diffuse Intrinsic Pontine Glioma (DIPG) Awareness Day in the state of Louisiana. This resolution serves to raise public awareness about DIPG, an aggressive and fatal brain tumor affecting children. This designation is intended to highlight the severity of this condition, which has a median survival time of only nine months following diagnosis and a zero percent survival rate. By promoting awareness, the resolution seeks to mobilize efforts towards greater research funding and support for affected families.
Sentiment
The sentiment surrounding SCR33 is predominantly positive and supportive. Legislators and advocates recognize the importance of raising awareness for DIPG and the necessity of addressing its impact on children's health. The resolution resonates with various stakeholders, including healthcare professionals and cancer advocacy groups, who hope that increased recognition will lead to better funding for research and support for children and families affected by this rare brain tumor. The general tone of the discussions indicates a shared commitment to address the challenges posed by DIPG and similar pediatric cancers.
Contention
While the resolution itself does not present significant points of contention, discussions surrounding the dire need for research funding and healthcare advancements highlight broader issues in pediatric cancer treatment. The limited resources allocated for pediatric cancer studies, particularly for brain tumors, remains a notable area of concern. Furthermore, the resolution indirectly calls for a reevaluation of health policies to better support children's healthcare needs and the search for effective treatments for aggressive cancers like DIPG.
Expressing support for the designation of May 17, 2026, as "DIPG Awareness Day" to raise awareness and encourage research into cures for diffuse intrinsic pontine glioma (DIPG) and pediatric cancers in general.
Expressing support for the designation of May 17, 2025, as "DIPG Awareness Day" to raise awareness and encourage research into cures for diffuse intrinsic pontine glioma (DIPG) and pediatric cancers in general.
A resolution expressing support for the designation of May 17, 2025, as "DIPG Pediatric Brain Cancer Awareness Day" to raise awareness of, and encourage research on, diffuse intrinsic pontine glioma tumors and pediatric cancers in general.
Designating June 15, 2026, as "Elora Joyce Khan Pediatric Brain Cancer Awareness Day" in Pennsylvania to promote education, compassion, advocacy and research related to pediatric brain cancer.